5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Haleos Labs Ltd.

•
haleoslabs.comBSE: 540679NSE: HALEOSLABS
Market Cap₹ 460 Cr.
Current Price
High / Low₹ 1,774 / 1,091
Stock P/E29.1
Book Value₹ 712
Price to Book1.66
Dividend Yield0.10 %
ROCE12.6 %
ROE10.0 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has consistently been profitable over the last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.00x)
  • Working capital cycle has improved - days down from 12 to 8
  • Company generates healthy free cash flow
  • Company has a consistent dividend-paying track record
  • Company maintains a comfortable, low leverage position

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Company has a low return on equity of 6.9% over last 3 years
  • Company has a low return on capital employed of 9.8%
  • Company has delivered a poor sales growth of 5.7% over past five years
  • Growth is decelerating - 3Y profit CAGR (-9.5%) trails the 5Y trend (13.0%)
  • Though reporting repeated profits, the company pays out little dividend (2.3%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1899.8037.69455825.660.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9305.0084.45247018.510.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4913.0085.68186874.730.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1155.0025.53115211.690.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1395.9533.46112773.000.93785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1868.2592.32100943.830.11362.07123.942026.3129.1018.2031.50
7.LUPIN2105.0017.4196254.460.861416.9816.018276.8934.2828.8629.59
8.MANKIND2322.0546.9595911.140.04574.0929.124030.5912.8913.2426.30
9.DRREDDY1145.0029.6695570.850.70435.60-69.108099.80-5.2113.7510.63
10.AUROPHARMA1658.0025.7095397.650.241032.0325.229150.3517.4412.7620.54
11.GLENMARK2462.0038.6569483.710.10482.83927.884018.4831.3520.3520.03
12.HALEOSLABS1520.0029.08459.540.101.84-58.0172.94-11.6012.6012.50
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
75697290937885898381957573
72616379767072827168817170
Operating Profit3891116913712141443
OPM %3.39%11.35%12.89%12.62%17.60%10.91%15.07%8.33%14.20%16.68%14.81%5.54%4.08%
1012020210020
Interest2323222222212
Depreciation4444444444444
Profit before Tax-32471157478913
Tax %-40.29%126.51%-8.14%8.87%33.27%29.79%29.77%11.45%37.61%24.38%24.26%61.54%46.48%
Net Profit0000735346702
-5.942.2414.2419.5322.9915.4618.089.8313.7520.1921.891.448.75

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
378261266350316306345324
343235235316287275300289
Operating Profit3525303529314535
OPM %9.20%9.74%11.39%9.86%9.13%10.20%13.08%10.72%
322145453
Interest655671096
Depreciation6881011151516
Profit before Tax2515203317102622
Tax %29.69%30.58%30.72%22.70%31.43%35.74%28.47%29.41%
Net Profit181014251161915
EPS59.0333.6844.8483.7637.9230.0866.51—
Dividend Payout %2.54%0.00%3.35%1.79%3.96%4.99%2.26%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
6%
3 Years:
-1%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
15%
3 Years:
-7%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
—

RETURN ON EQUITY

10 Years:
—
5 Years:
10%
3 Years:
7%
Last Year:
10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2025

Sep 24

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2024

Sep 23

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2023

Sep 22

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2022

Sep 22

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2021

Sep 20

₹ 0.15

Rs.1.5000 per share(15%)Dividend

2026

May 29

₹ 0.15

Rs.1.5000 per share(15%)Final Dividend

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital3333333
Minority Interest00013201715
103113126149166174194
466470791008270
Trade Payables98496778605953
26274142516063
Total Liabilities276256307364398395399
117124130142228223232
Capital Work in Progress3163851160
81646285868167
000005169
Cash & Bank38114412
72446682783129
Total Assets276256307364398395399

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
371840-4182434
Cash from Investing-44-27-26-7-31-18-15
Cash from Financing1512-31117-7-19
1-06-80-1-0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025

Shareholding Pattern

Numbers in percentages

Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
71.4171.4171.4171.4171.4171.8072.1172.11
0.020.000.000.030.000.000.000.00
0.000.000.000.000.030.290.300.31
Government0.000.000.000.000.000.000.000.00
28.5728.5928.5928.5628.5727.9127.6027.58

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-08
Copy of Newspaper Publication

2026-09-08 - HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication for AGM notice

2026-09-08
Shareholders meeting

2026-09-08 - HALEOS LABS LIMITED has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026

2026-09-05
General Updates

2026-09-05 - HALEOS LABS LIMITED has informed the Exchange about Events Calendar (AGM)

2026-09-05
Record Date

2026-09-05 - HALEOS LABS LIMITED has informed the Exchange that Record date for the purpose of Dividend is 23-Sep-2026.

2026-09-01
Shareholders meeting

2026-09-01 - HALEOS LABS LIMITED has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

2026-08-24
Updates

2026-08-24 - HALEOS LABS LIMITED has informed the Exchange regarding 'Communication To Shareholders (TDS Related)'.

2026-08-07
Copy of Newspaper Publication

2026-08-07 - HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication

2026-08-05
Updates

2026-08-05 - HALEOS LABS LIMITED has informed the Exchange regarding 'Update (Material Subsidiary)'.

2026-08-05
Change in Director(s)

2026-08-05 - HALEOS LABS LIMITED has informed the Exchange regarding Change in Director(s) of the company.

News

Recent coverage and analyst commentary for HALEOSLABS

Loading news…

🤖

AI Stock Analyst

Haleos Labs Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login